Wang Shuo, Shi Huasheng, Liu Tao, Li Manjiang, Zhou Sanshun, Qiu Xuan, Wang Zusen, Hu Weiyu, Guo Weidong, Chen Xiaoqian, Guo Honglin, Shi Xiaoliang, Shi Junping, Zang Yunjin, Cao Jingyu, Wu Liqun
Liver Disease Center, Affiliated Hospital of Qingdao University, Qingdao, China.
Department of Hepatobiliary Surgery, Affiliated Hospital of Jining Medical University, Jining, China.
Hepatobiliary Surg Nutr. 2021 Apr;10(2):172-179. doi: 10.21037/hbsn.2019.09.17.
Hepatocellular carcinoma (HCC) is one of the most common causes of cancer worldwide. Although many studies have focused on oncogene characteristics, the genomic landscape of Chinese HCC patients has not been fully clarified.
A total of 165 HCC patients, including 146 males and 19 females, were enrolled. The median age was 55 years (range, 27-78 years). Corresponding clinical and pathological information was collected for further analysis. A total of 168 tumor tissues from these patients were selected for next-generation sequencing (NGS)-based 450 panel gene sequencing. Genomic alterations including single nucleotide variations (SNV), short and long insertions and deletions (InDels), copy number variations, and gene rearrangements were analyzed. Tumor mutational burden (TMB) was measured by an algorithm developed in-house. The top quartile of HCC was classified as TMB high.
A total of 1,004 genomic alterations were detected from 258 genes in 168 HCC tissues. TMB values were identified in 160 HCC specimens, with a median TMB of 5.4 Muts/Mb (range, 0-28.4 Muts/Mb) and a 75% TMB of 7.7 Muts/Mb. The most commonly mutated genes were , and . SNV was the most common mutation type and C:G>T:A and guanine transformation were the most common SNVs. Compared to wild-type patients, the proportion of Edmondson grade III-IV and microvascular invasion was significantly higher in mutated patients (P<0.05). The proportion of tumors invading the hepatic capsule was significantly higher in mutated patients (P<0.05). The proportion of Edmondson grade I-II, alpha fetoprotein (AFP) <25 µmg/L, and those without a history of hepatitis B was significantly higher in mutated patients (P<0.05). mutations were associated with TMB high in HCC patients (P<0.05). Based on correlation analysis, the mutation of was independently correlated with microvascular invasion (P=0.002, OR =3.096) and Edmondson grade III-IV (P=0.008, OR =2.613). The mutation of was independently correlated with tumor invasion of the liver capsule (P=0.001, OR =3.030), and the mutation of was independently correlated with AFP (<25 µmg/L) (P=0.009, OR =3.414).
The most frequently mutated genes of HCC patients in China were , , and , which mainly lead to the occurrence and development of HCC by regulating the P53 pathway, Wnt pathway, and telomere repair pathway. There were more patients with microvascular invasion and Edmondson III-IV grade in mutated patients and more patients with hepatic capsule invasion in mutated patients, while in mutated patients, there were more patients with Edmondson I-II grade, AFP <25 µmg/L, and a non-hepatitis B background. Also, the TMB values were significantly higher in mutated patients than in wild type patients.
肝细胞癌(HCC)是全球癌症最常见的病因之一。尽管许多研究聚焦于癌基因特征,但中国HCC患者的基因组格局尚未完全阐明。
共纳入165例HCC患者,其中男性146例,女性19例。中位年龄为55岁(范围27 - 78岁)。收集相应的临床和病理信息用于进一步分析。从这些患者中选取168个肿瘤组织进行基于二代测序(NGS)的450基因panel测序。分析基因组改变,包括单核苷酸变异(SNV)、短插入和缺失(InDels)、拷贝数变异以及基因重排。通过内部开发的算法测量肿瘤突变负荷(TMB)。HCC的前四分位数被分类为TMB高。
在168个HCC组织中的258个基因中总共检测到1004个基因组改变。在160个HCC标本中确定了TMB值,中位TMB为5.4个突变/Mb(范围0 - 28.4个突变/Mb),75%的TMB为7.7个突变/Mb。最常突变的基因是 , ,和 。SNV是最常见的突变类型,C:G>T:A和鸟嘌呤转化是最常见的SNV。与野生型患者相比, 突变患者中Edmondson III - IV级和微血管侵犯的比例显著更高(P<0.05)。 突变患者中肿瘤侵犯肝包膜的比例显著更高(P<0.05)。 突变患者中Edmondson I - II级、甲胎蛋白(AFP)<25μg/L以及无乙肝病史的患者比例显著更高(P<0.05)。 突变与HCC患者的TMB高相关(P<0.05)。基于相关性分析, 的突变与微血管侵犯独立相关(P = 0.002,OR = 3.096)和Edmondson III - IV级(P = 0.008,OR = 2.613)。 的突变与肝包膜肿瘤侵犯独立相关(P = 0.001,OR = 3.030), 的突变与AFP(<25μg/L)独立相关(P = 0.009,OR = 3.414)。
中国HCC患者最常突变的基因是 , ,和 ,它们主要通过调节P53途径、Wnt途径和端粒修复途径导致HCC的发生和发展。 突变患者中微血管侵犯和Edmondson III - IV级的患者更多, 突变患者中肝包膜侵犯的患者更多,而 突变患者中Edmondson I - II级、AFP<25μg/L以及无乙肝背景的患者更多。此外, 突变患者的TMB值显著高于野生型患者。